Is "Cure" possible in metastatic Melanoma by Immune Checkpoint Inhibition

被引：0
|
作者：
Koett, Julian [1 ]
Hildebrandt, Lina [1 ]
Heidrich, Isabel [1 ]
Geidel, Glenn [1 ]
Hansen, Inga [1 ]
Schneider, StefanW. [1 ]
Gebhardt, Christoffer [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Dermatol & Venerol, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P297
引用
收藏
页码：164 / 165
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma
    Fan, Kelly
    Waninger, Jessica J.
    Yentz, Sarah
    McLean, Scott
    Demirci, Hakan
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (05): : E152 - E155
  • [2] Investigation of the immune infiltrate of metastatic melanoma under immune checkpoint inhibition
    Hassel, J. C.
    Flossdorf, M.
    Haenzelmann, S.
    Winkler, J.
    Appel, L.
    Streit, E.
    Halama, N.
    Faryna, M.
    Poschke, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S244 - S244
  • [3] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Francesca Aroldi
    Mark R. Middleton
    American Journal of Clinical Dermatology, 2022, 23 : 331 - 338
  • [4] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Aroldi, Francesca
    Middleton, Mark R.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 331 - 338
  • [5] Peripheral blood biomarkers in immune checkpoint inhibition therapy in metastatic melanoma
    Ghelani, Ghanshyam H.
    Mandava, Anupa
    Zerdan, Maroun Bou
    Mehta, Radhika
    Sivapiragasam, Abirami
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
    Waninger, Jessica J. J.
    Fecher, Leslie A. A.
    Lao, Christopher
    Yentz, Sarah
    Green, Michael D. D.
    Demirci, Hakan
    CANCERS, 2022, 14 (23)
  • [7] Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma
    Mochel, Mark C.
    Ming, Michael E.
    Imadojemu, Sotonye
    Gangadhar, Tara C.
    Schuchter, Lynn M.
    Elenitsas, Rosalie
    Payne, Aimee S.
    Chu, Emily Y.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (09) : 787 - 791
  • [8] Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management
    Lomax, Anna J.
    Lim, Jennifer
    Cheng, Robert
    Sweeting, Arianne
    Lowe, Patricia
    McGill, Neil
    Shackel, Nicholas
    Chua, Elizabeth L.
    McNeil, Catriona
    JOURNAL OF SKIN CANCER, 2018, 2018
  • [9] Immune Checkpoint Inhibitors in the Treatment of Metastatic Melanoma
    Mier, James W.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 753 - 754
  • [10] Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients
    Kudura, Ken
    Nussbaumer, Lukas
    Foerster, Robert
    Basler, Lucas
    BIOMEDICINES, 2022, 10 (09)
12345